Gapping up
In reaction to earnings/guidance:
- GLNG +0.5%
Select airline stocks trading higher:
- SAVE +1.1%, LUV +0.7%, JBLU +0.7%, UAL +0.6%, DAL +0.6%
Other news:
- AAIC +51.3% (to be acquired by Ellington Financial (EFC) for $4.77 per share)
- ETRN +26.4% (Mountain Valley natural gas pipeline approval in West Virginia)
- LXRX +21.1% (announces FDA approval of INPEFA (sotagliflozin) for treatment of heart failure)
- IOVA +19.7% (received FDA Acceptance of BLA for Lifileucel)
- CCCC +12.3% (C4 Therapeutics and Betta Pharmaceuticals announced an exclusive licensing agreement for the development and commercialization of CFT8919 in Greater China)
- AKBA +10.6% (FDA provides Akebia Therapeutics a path forward for Vadadustat)
- COHR +9.4% (details May 2023 Restructuring Plan)
- NFLX +4.8% (positive Barron's article)
- NVDA +3.8% (announces DGX GH200 AI Supercomputer and several other product updates)
- SMCI +3.8% (COMPUTEX keynote unveils company's Accelerate Everything Strategy for product innovation, manufacturing scale, and green technology)
- MX +3.2% (announces plan to separate display and power businesses)
- SONO +2.2% (wins $32.5 mln patent case against Google)
- NWL +2% (announces restructuring and savings initiative that is intended to simplify and streamline its North American distribution network)
- SHOP +1.8% (nominates former Salesforce co-CEO Bret Taylor to join its board of directors)
- NNDM +1.7% (Stratasys Board of Directors unanimously rejects Nano Dimension's (NNDM) partial tender offer)
- STNE +1.5% (promotes Mateus Scherer as new CFO)
- MU +1.2% (Commerce Secretary Gina Raimondo says US "won't tolerate" Micron (MU) chip ban)
- BTE +1.2% (brought back onstream the full 24,000 boe/d of production that was shut-in as a result of the Alberta wildfires)
Analyst comments:
- CHPT +5.2% (upgraded to Buy from Neutral at BofA Securities)
- COIN +4.2% (upgraded to Overweight from Neutral at Atlantic Equities)
- F +3.2% (upgraded to Buy from Hold at Jefferies)
- SAM +1.4% (upgraded to Buy from Neutral at ROTH MKM)
- HEI +0.9% (upgraded to Buy from Hold at Vertical Research)
- LNT +0.8% (upgraded to Outperform from Market Perform at BMO Capital Markets)
- STZ +0.8% (upgraded to Buy from Neutral at ROTH MKM)